by H. Lee Moffitt Cancer Center & Research Institute Lung CA seen on CXR. Credit: James Heilman, MD/Wikipedia Immunotherapy has become an important tool in the treatment of lung cancer, especially checkpoint inhibitors that block certain immune checkpoints to allow immune cells to recognize and kill cancer cells. Several checkpoint inhibitors targeting PD-1 and PD-L1 have been approved...
